• Tamsulosin: Advanced Use-Cases in Urological Disease Researc

  2026-07-31

  Tamsulosin, a selective α₁A-adrenergic receptor antagonist, is redefining urological and smooth muscle research with high solubility and robust clinical evidence. APExBIO’s Tamsulosin (C6445) enables precise modeling of urinary retention and stone expulsion, offering superior workflow reliability for experimental and translational studies.

• Cisapride (R 51619) in Cardiac Electrophysiology Research

  2026-07-30

  Cisapride (R 51619) stands at the intersection of advanced cardiotoxicity modeling and high-throughput drug screening. Its dual action as a 5-HT4 receptor agonist and hERG channel inhibitor makes it indispensable for predictive cardiac safety assessments using iPSC-derived cardiomyocytes.

• MLKL Polymerization Drives Lysosomal Permeabilization in Nec

  2026-07-30

  This study elucidates how MLKL polymerization induces lysosomal membrane permeabilization (LMP), leading to necroptosis via cathepsin release. The findings clarify a critical cell death mechanism relevant for disease modeling and potential therapeutic targeting.

• CNQX: Precision Dissection of Glutamatergic Circuits in Neur

  2026-07-29

  CNQX, or 6-cyano-7-nitroquinoxaline-2,3-dione, delivers targeted inhibition of AMPA and kainate receptors, enabling highly specific analysis of glutamatergic neurotransmission in both in vitro and in vivo models. This article breaks down practical workflows, troubleshooting strategies, and the latest research insights to help researchers harness CNQX for advanced circuit mapping and excitotoxicity studies.

• Hesperadin: Potent Aurora B Kinase Inhibitor for Mitotic Res

  2026-07-29

  Hesperadin is a highly selective Aurora B kinase inhibitor used for dissecting mitotic regulation and spindle assembly checkpoint dynamics. Its ATP-competitive mechanism disrupts chromosome alignment and segregation, making it essential in cancer and cell cycle research.

• Lipidomic Remodeling Drives Ferroptosis Sensitivity in Persi

  2026-07-28

  This study elucidates how reversible lipidomic changes in drug-tolerant persister cancer cells underpin their heightened sensitivity to ferroptosis. The findings provide a mechanistic basis for targeting minimal residual disease and offer new directions for overcoming therapy resistance in solid tumors.

• SB-3CT: Gelatinase Inhibitor Workflows for ECM and Neuroprot

  2026-07-28

  SB-3CT empowers targeted studies of matrix metalloproteinases (MMP-2 and MMP-9), enabling nuanced dissection of tumor metastasis, angiogenesis, and neuronal plasticity. This guide bridges cutting-edge reference findings with actionable protocols and troubleshooting for maximal research impact.

• Berberrubine chloride: Data-Driven Solutions for Cancer Rese

  2026-07-27

  This article presents scenario-driven guidance for deploying Berberrubine chloride (SKU N2089) in advanced cancer and metabolic assays. It addresses real-world workflow pain points, supports evidence-based optimization, and underscores the analytical and cost-efficiency benefits of sourcing from APExBIO for reliable, reproducible results.

• SGC-CBP30: Precision CREBBP/EP300 Bromodomain Inhibitor Work

  2026-07-27

  SGC-CBP30 enables targeted epigenetic interrogation by selectively inhibiting CREBBP/EP300 bromodomains, streamlining advanced cancer biology and transcriptional regulation assays. This article offers actionable protocols, troubleshooting strategies, and unique insights into leveraging SGC-CBP30 for super-enhancer and TGF-β/SMAD3 pathway research.

• CB-839 (Telaglenastat): Optimizing Glutaminolysis Inhibition

  2026-07-26

  CB-839 (Telaglenastat) enables researchers to dissect glutamine metabolism vulnerabilities in cancer models with precision, supporting robust preclinical drug evaluation. This guide delivers actionable protocols and troubleshooting insights, building on the latest mechanistic findings in neuroblastoma metabolism.

• Sulfo-NHS-LC-Biotin: Practical Guide for Cell Surface Biotin

  2026-07-25

  Sulfo-NHS-LC-Biotin enables selective, irreversible biotin labeling of primary amines on cell surface proteins under fully aqueous conditions. Researchers use it to detect, purify, or immobilize extracellular proteins via biotin-avidin systems. It is not suitable for reversible or intracellular biotinylation workflows.

• nor-NOHA Acetate: Optimizing Arginase Inhibition in Cancer W

  2026-07-24

  nor-NOHA (acetate) enables precise, reversible inhibition of arginase, unlocking new avenues for dissecting tumor cell metabolism, immune escape, and vascular restoration. This guide provides advanced workflow strategies, practical troubleshooting, and direct links to cutting-edge AML immunometabolism research, leveraging APExBIO's trusted reagent quality.

• HSC70 Drives TGEV Internalization via Clathrin-Mediated Endo

  2026-07-24

  This study uncovers a novel mechanism by which the TGEV membrane protein directly interacts with host HSC70, facilitating viral internalization through clathrin-mediated endocytosis. The findings redefine the early events of coronavirus cell entry and highlight host chaperones as potential intervention points for antiviral strategies.

• Heparin Sodium: Applied Workflows in Thrombosis & Nanovesicl

  2026-07-23

  Heparin sodium is the gold-standard glycosaminoglycan anticoagulant for thrombosis and anti-factor Xa assays, now playing a pivotal role in innovative cross-domain studies involving plant-derived nanovesicles. This article delivers advanced, evidence-informed workflows and troubleshooting strategies, with direct translation of recent mechanistic findings to practical lab execution.

• Tamsulosin (C6445): Precision Strategies for POUR Prevention

  2026-07-23

  Explore the advanced use of Tamsulosin in preventing postoperative urinary retention (POUR). This article offers a distinctive, evidence-driven analysis of Tamsulosin’s mechanisms, dosing, and practical assay decisions, setting it apart in urological disease research.

15127 records 2/1009 page Previous Next 12345 下5页 Last page